Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PRISM LAB LLC

NPI: 1861960510 · ROCHESTER HILLS, MI 48307 · Clinical Medical Laboratory · NPI assigned 11/10/2018

$126K
Total Medicaid Paid
2,893
Total Claims
1,909
Beneficiaries
3
Codes Billed
2020-12
First Month
2023-12
Last Month

Provider Details

Authorized OfficialRUEFIEL, JOSEPH (MANAGER)
NPI Enumeration Date11/10/2018

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 48 $2K
2021 1,078 $44K
2022 1,497 $57K
2023 270 $23K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,305 822 $80K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,318 825 $24K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 270 262 $23K